• Home
  • Life Sciences

Training courses & Webinars:
Life Sciences

Our life sciences training courses cover Pharmaceuticals, Medical Devices, IVDs, Biotech/Biopharma and Animal Health and have been designed to focus on regulatory affairs, clinical trials, pharmacovigilance, medical writing, latest developments, and best practices (GxP).  Our portfolio of events is extensive and provides training from basic to advanced levels in a variety of formats.  

The pandemic created numerous challenges across all areas of business worldwide and companies had to respond and adapt very quickly. Now, as the healthcare sector emerges stronger and with renewed strategy, life science companies continue to focus on key areas for development, explore the use of emerging technologies, and seek opportunities to harness collaborations and build resilience. 

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Next events:

  • 21-22 May 2025 Biosimilars
  • 26-27 Jun 2025 Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

See all 8 courses

Next events:

  • 7 Apr 2025 Data Integrity and Document Management
  • 6-7 May 2025 Clinical Trial Monitoring

See all 31 courses

GxP

Next events:

  • 7 Apr 2025 Data Integrity and Document Management
  • 12 May 2025 ICH Q9(R1) Quality Risk Management (QRM)

See all 39 courses

Next events:

  • 1-2 Apr 2025 An Introduction to the Design and Development of Medical Devices
  • 8-9 May 2025 Cyber Security for Medical Devices

See all 15 courses

Next events:

  • 5 Jun 2025 Effective Technical Writing & Editing
  • 5-6 Jun 2025 Successful Medical Writing – from Protocol to CTD

See all 6 courses

Next events:

  • 27 Mar 2025 Best Practice for Writing Effective SOPs
  • 31 Mar-1 Apr 2025 FDA Approval Process for Medical Devices

See all 84 courses

Next events:

  • 24-26 Mar 2025 Advanced Pharmacovigilance
  • 15 May 2025 An Essential Overview of Pharmacovigilance

See all 27 courses

Overall, this is a good seminar. It is a little long, but that is to be expected looking at the contents and countries to be covered. 5* - I would recommend.

Kong Kong Weng-Yip, Assistant Manager RA, DUOPHARMA (M) SENDIRIAN BERHAD

Overall, it was a wonderful webinar and has helped me further expand my knowledge on the EU/UK regulations. I look forward to participating in future webinars.

Iva Martinovic, Medical Information Professional, Teva

My expectation was to gain as much knowledge as possible about EAEU regulations. It was very helpful and useful to get EAEU region overview and understand regulatory approach in each country.

Maryna Orudzheva, Regulatory Manager CIS, Accord Healthcare Polska Sp. z o.o.

The presentation was outstanding. The presenters were welcoming. The session was interactive and insightful.

Vivian Ilonzeh, Director Reg Operations, Bristol Myer Squibb

This was an excellent webinar. Very useful and [speaker] has a lot of knowledge and experience, giving us examples from real life, making the concepts easier to understand and the course more enjoyable, was fantastic - kept me engaged the entire time. Very well organized.

Maria Jesus Lopez Villanueva, QA Administrator Eng, Endomag

Very good seminar which covered all important points around the production and maintenance of the PSMF. The speaker was excellent with a profound knowledge of the topic.

Marie-Christine Klös, Global PV Specialist, Boehringer Ingelheim Vetmedica GmbH

Very Good. I wanted to get an overview of EU Pharmaceutical Regulations and to understand regulatory strategies to bring new products quickly into the market. The course covered everything I needed and even more.

Chitra Saxena, Senior Manager Regulatory Affairs, Lupin Healthcare (UK) Limited

It was very useful to have specific ideas, tools, websites and portals introduced as to what should be done for CRO oversight.

Kenji Tada, Unit Manager, Clinical Operation Unit, JCR Pharmaceuticals Co

Very good. [Speaker was] very experienced.

Celine Anselmetti Dayer, Director, Regulatory Affairs, Debiopharm Research & Manufacturing SA

Very good.

Peter Wæde Hansen, Senior International Medical Manager, Novo Nordisk AS